Chung M H, Chuang C C, Liaw L F, Chen C Y, Chen I M, Hsu C P, Lin N C, Loong C C
Division of Transplantation Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Trauma, Emergency Department, Taipei Veterans General Hospital, Taipei, Taiwan.
Division of Transplantation Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Transplant Proc. 2018 Nov;50(9):2606-2610. doi: 10.1016/j.transproceed.2018.04.050. Epub 2018 May 1.
The safety of the living donor in living-donor liver transplantation (LDLT) is always the first priority, meanwhile, the graft-to-recipient weight ratio (GRWR) and the anatomy of the liver allograft must also not be compromised in order to warrant tranplatation success. When it comes to the allograft of the right lobe of the liver without the middle hepatic vein (R-M), the outflow and adequate drainage for the territory of middle hepatic vein (MHV) is one critical concern. Despite publications in some high-volume transplant centers on the positive results of using expanded polytetrafluoroethylene (ePTFE) grafts to substitute those of autologous veins, complications related to the ePTFE graft have not been well discussed.
From July 2012 to June 2016, 129 adult patients who underwent living donor liver transplantation in Taipei Veterans General Hospital were analyzed. There were 3 cases of adjacent organ erosion with gas bubbles in the lumen of an ePTFE graft, including gastrointestinal (GI) tract penetration in 2 out of the first 15 cases that used the venous graft of ringed expanded polytetrafluoroethylene (rPTFE). The patient survival rate during this period was compared and radiological findings of rPTFE function and clinical signs of erosion with infection were also examined to raise the concerns of safety as well as early detection of complications of rPTFE.
The overall 1-year patient survival rate was 90%, of which the right lobe wih MHV (R+M) group was 93.5% and the R-M group was 91.9%. For the mean of GRWR, the R+M group was 1.05 ± 0.19 and R-M group was 1.19 ± 0.27, while those who needed reconstruction with vein grafts was 0.96 ± 0.11. Among the R-M group, 24 out of 88 cases (27.3%) needed reconstruction of MHV tributaries. Of the 24 cases, 15 cases were done with rPTFE and the 1-year patient survival rate of the rPTFE group was 73%, which is significantly worse (P = .008) than the non-rPTFE (89%) and non-reconstructed (97%) groups. The mean GRWR is significantly higher (P = .001) in the non-reconstructed group (1.19 ± 0.27) than in the rPTFE (0.99 ± 0.11) and non-rPTFE (0.94 ± 0.11) groups. The venous grafts patency rate between the different graft types is no different, and there is also significance in warm ischemic time (P = .009) between the non-reconstructed (49 ± 15), rPTFE (81 ± 51), and non-rPTFE (56 ± 18) groups in the mean minutes.
In cases of fever of unknown cause in patients receiving LDLT with rPTFE graft, a regular computed tomography (CT) scan with contrast and gas bubbles within the graft lumen is the best way for early detection of graft related infection and suspicious GI tract penetration. To decrease the risks of tissue reaction induced by ePTFE graft in LDLT, omentum patches or other inert agents can be introduced as a buffer between the graft and adjacent organs, especially the GI tracts. However, research in material science shall be explored to solve the problem in the future.
活体肝移植(LDLT)中活体供体的安全始终是首要考虑因素,同时,为确保移植成功,供肝与受体的重量比(GRWR)以及移植肝的解剖结构也不能受到影响。对于不含肝中静脉的右半肝移植(R-M)而言,肝中静脉(MHV)区域的血流流出及充分引流是一个关键问题。尽管一些大型移植中心发表了关于使用膨体聚四氟乙烯(ePTFE)移植物替代自体静脉取得积极成果的报道,但与ePTFE移植物相关的并发症尚未得到充分讨论。
对2012年7月至2016年6月在台北荣民总医院接受活体肝移植的129例成年患者进行分析。有3例出现ePTFE移植物管腔内伴有气泡的邻近器官侵蚀,其中在前15例使用环状膨体聚四氟乙烯(rPTFE)静脉移植物的患者中有2例发生胃肠道(GI)穿孔。比较了这一时期的患者生存率,并检查了rPTFE功能的影像学表现以及伴有感染的侵蚀临床体征,以提高对rPTFE安全性的关注以及对其并发症的早期检测。
总体1年患者生存率为90%,其中含MHV的右半肝(R+M)组为93.5%,R-M组为91.9%。GRWR的平均值方面,R+M组为1.05±0.19,R-M组为1.19±0.27,而需要静脉移植物重建的患者为0.96±0.11。在R-M组中,88例中有24例(27.3%)需要重建MHV分支。在这24例中,15例采用rPTFE进行重建,rPTFE组的1年患者生存率为73%,明显低于非rPTFE组(89%)和未重建组(97%)(P = 0.008)。未重建组的平均GRWR(1.19±0.27)显著高于rPTFE组(0.99±0.11)和非rPTFE组(0.94±0.11)(P = 0.001)。不同移植物类型之间的静脉移植物通畅率无差异,非重建组(49±15)、rPTFE组(81±51)和非rPTFE组(56±18)的平均热缺血时间(分钟)也存在显著差异(P = 0.009)。
对于接受rPTFE移植物的LDLT患者出现不明原因发热的情况,定期进行增强计算机断层扫描(CT)并观察移植物管腔内的气泡是早期发现移植物相关感染和可疑胃肠道穿孔的最佳方法。为降低LDLT中ePTFE移植物引起的组织反应风险,可在移植物与邻近器官(尤其是胃肠道)之间引入网膜补片或其他惰性物质作为缓冲。然而,未来仍需探索材料科学方面的研究来解决这一问题。